249 related articles for article (PubMed ID: 14985542)
61. Screening isolates from antibody phage-display libraries.
Buckler DR; Park A; Viswanathan M; Hoet RM; Ladner RC
Drug Discov Today; 2008 Apr; 13(7-8):318-24. PubMed ID: 18405844
[TBL] [Abstract][Full Text] [Related]
62. The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries.
Kramer RA; Marissen WE; Goudsmit J; Visser TJ; Clijsters-Van der Horst M; Bakker AQ; de Jong M; Jongeneelen M; Thijsse S; Backus HH; Rice AB; Weldon WC; Rupprecht CE; Dietzschold B; Bakker AB; de Kruif J
Eur J Immunol; 2005 Jul; 35(7):2131-45. PubMed ID: 15971273
[TBL] [Abstract][Full Text] [Related]
63. Single-chain variable fragment (scFv) antibodies optimized for environmental analysis of uranium.
Zhu X; Kriegel AM; Boustany CA; Blake DA
Anal Chem; 2011 May; 83(10):3717-24. PubMed ID: 21473651
[TBL] [Abstract][Full Text] [Related]
64. Modulation of Epstein-Barr virus latent membrane protein 1 activity by intrabodies.
Fang CY; Chiang CY; Pan YR; Tse KP; Chang YS; Chang HY
Intervirology; 2007; 50(4):254-63. PubMed ID: 17460414
[TBL] [Abstract][Full Text] [Related]
65. Humanization of agonistic anti-human 4-1BB monoclonal antibody using a phage-displayed combinatorial library.
Son JH; Lee UH; Lee JJ; Kwon B; Kwon BS; Park JW
J Immunol Methods; 2004 Mar; 286(1-2):187-201. PubMed ID: 15087232
[TBL] [Abstract][Full Text] [Related]
66. Human IgG1 Cgamma1 domain is crucial for the bioactivity of the engineered anti-CD20 antibodies.
Geng S; Feng J; Li Y; Kang X; Sun Y; Gu X; Huang Y; Chang H; Shen BF
Cell Mol Immunol; 2007 Apr; 4(2):121-5. PubMed ID: 17484806
[TBL] [Abstract][Full Text] [Related]
67. [Screening of single-chain variable fragment (scFv) to bone sialoprotein].
Wang JT; Wang J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):979-81. PubMed ID: 21906471
[TBL] [Abstract][Full Text] [Related]
68. Adapting pharmacokinetic properties of a humanized anti-interleukin-8 antibody for therapeutic applications using site-specific pegylation.
Leong SR; DeForge L; Presta L; Gonzalez T; Fan A; Reichert M; Chuntharapai A; Kim KJ; Tumas DB; Lee WP; Gribling P; Snedecor B; Chen H; Hsei V; Schoenhoff M; Hale V; Deveney J; Koumenis I; Shahrokh Z; McKay P; Galan W; Wagner B; Narindray D; Hébert C; Zapata G
Cytokine; 2001 Nov; 16(3):106-19. PubMed ID: 11741351
[TBL] [Abstract][Full Text] [Related]
69. Modified peptide antagonists of interleukin 5 exhibit extended in vivo persistence but restricted species specificity.
Uings IJ; Balasubramanian P; McLoughlin PG; Yin Q; Dash L; Beresford A; Kearney S; Barrett RW; McKinnon M; England BP
Cytokine; 2001 Jul; 15(1):10-9. PubMed ID: 11509004
[TBL] [Abstract][Full Text] [Related]
70. Selection of scFv Antibody Fragments Binding to Human Blood versus Lymphatic Endothelial Surface Antigens by Direct Cell Phage Display.
Keller T; Kalt R; Raab I; Schachner H; Mayrhofer C; Kerjaschki D; Hantusch B
PLoS One; 2015; 10(5):e0127169. PubMed ID: 25993332
[TBL] [Abstract][Full Text] [Related]
71. A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist.
Schreuder H; Tardif C; Trump-Kallmeyer S; Soffientini A; Sarubbi E; Akeson A; Bowlin T; Yanofsky S; Barrett RW
Nature; 1997 Mar; 386(6621):194-200. PubMed ID: 9062194
[TBL] [Abstract][Full Text] [Related]
72. An antibody to a 17 amino acid synthetic peptide of the type I interleukin-1 receptor preferentially blocks interleukin-1 beta binding.
Clark BD; Ikejima T; Mancilla J; Orencole SF; Sirko SP; Ishii N; Okuda K; Dinarello CA
J Interferon Cytokine Res; 1996 Dec; 16(12):1079-88. PubMed ID: 8974012
[TBL] [Abstract][Full Text] [Related]
73. Monoclonal antibodies reacting with the interleukin 1 receptor define a multi-molecular complex.
Lewis C; Mazzei G; Shaw A
Eur J Immunol; 1990 Jan; 20(1):207-13. PubMed ID: 2137781
[TBL] [Abstract][Full Text] [Related]
74. Molecular immunolabeling with recombinant single-chain variable fragment (scFv) antibodies designed with metal-binding domains.
Malecki M; Hsu A; Truong L; Sanchez S
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):213-8. PubMed ID: 11756693
[TBL] [Abstract][Full Text] [Related]
75. A novel approach for immunization, screening and characterization of selected scFv libraries using membrane fractions of tumor cells.
Tur MK; Rothe A; Huhn M; Goerres U; Klimka A; Stöcker M; Engert A; Fischer R; Finner R; Barth S
Int J Mol Med; 2003 Apr; 11(4):523-7. PubMed ID: 12632108
[TBL] [Abstract][Full Text] [Related]
76. IL-1 induces rapid phosphorylation of the IL-1 receptor.
Gallis B; Prickett KS; Jackson J; Slack J; Schooley K; Sims JE; Dower SK
J Immunol; 1989 Nov; 143(10):3235-40. PubMed ID: 2530274
[TBL] [Abstract][Full Text] [Related]
77. A cell-free, nonisotopic, high-throughput assay for inhibitors of type-I interleukin-1 receptor.
Sarubbi E; Yanofsky SD; Barrett RW; Denaro M
Anal Biochem; 1996 May; 237(1):70-5. PubMed ID: 8660539
[TBL] [Abstract][Full Text] [Related]
78. Characterization and detection of naturally occurring antibodies against IL-1 alpha and IL-1 beta in normal human plasma.
Gallay P; Mach JP; Carrel S
Eur Cytokine Netw; 1991; 2(5):329-38. PubMed ID: 1839507
[TBL] [Abstract][Full Text] [Related]
79. Multimerization domains for antibody phage display and antibody production.
Thie H; Binius S; Schirrmann T; Hust M; Dübel S
N Biotechnol; 2009 Dec; 26(6):314-21. PubMed ID: 19631299
[TBL] [Abstract][Full Text] [Related]
80. Characterization of an IL-1 receptor from Asterias forbesi coelomocytes.
Beck G; Ellis TW; Truong N
Cell Immunol; 2000 Jul; 203(1):66-73. PubMed ID: 10915563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
